RobininCAS# 301-19-9 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 301-19-9 | SDF | Download SDF |
PubChem ID | 5281693 | Appearance | Yellow powder |
Formula | C33H40O19 | M.Wt | 740.7 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in hot water | ||
Chemical Name | 5-hydroxy-2-(4-hydroxyphenyl)-7-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-3-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one | ||
SMILES | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)OC5C(C(C(C(O5)C)O)O)O)C6=CC=C(C=C6)O)O)O)O)O)O)O | ||
Standard InChIKey | PEFASEPMJYRQBW-HKWQTAEVSA-N | ||
Standard InChI | InChI=1S/C33H40O19/c1-10-19(36)23(40)26(43)31(47-10)46-9-17-21(38)25(42)28(45)33(51-17)52-30-22(39)18-15(35)7-14(49-32-27(44)24(41)20(37)11(2)48-32)8-16(18)50-29(30)12-3-5-13(34)6-4-12/h3-8,10-11,17,19-21,23-28,31-38,40-45H,9H2,1-2H3/t10-,11-,17+,19-,20-,21-,23+,24+,25-,26+,27+,28+,31+,32-,33-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Robinin has cardioprotective effect on doxorubicin-induced cardiac toxicity by modulating TGF-β1 signaling pathway in Sprague Dawley rats. Robinin has protective effect against the ox-LDL induced inflammation stress in hPBMCs by inhibiting TLR4-NF-κB signaling pathway. |
Targets | TLR | NF-kB | LDL | COX | LOX | NOS | PGE | p65 | TGF-β/Smad |
In vitro | Robinin modulates TLR/NF-κB signaling pathway in oxidized LDL induced human peripheral blood mononuclear cells.[Pubmed: 24295649]Int Immunopharmacol. 2014 Jan;18(1):191-7.This study was designed to investigate whether Robinin administration modulates toll-like receptor (TLR) and nuclear factor-kappa B (NF-κB) signaling pathway in oxidized LDL induced human peripheral blood mononuclear cells (hPBMCs). |
In vivo | Robinin modulates doxorubicin-induced cardiac apoptosis by TGF-β1 signaling pathway in Sprague Dawley rats.[Pubmed: 25443416]Biomed Pharmacother. 2014 Oct;68(8):989-98.The study focussed on the cardioprotective effect of Robinin on doxorubicin-induced cardio-toxicity in Sprague Dawley rats. |
Structure Identification | J Pharm Biomed Anal. 2011 Apr 28;55(1):109-13.Simultaneous determination of the flavonoids robinin and kaempferol in human breast cancer cells by liquid chromatography-tandem mass spectrometry.[Pubmed: 21232900]An accurate, precise and sensitive method was developed and validated for the simultaneous quantification of the flavonoid glycoside Robinin, and its algycone kaempferol in human breast cancer MCF-7 cells. |
Robinin Dilution Calculator
Robinin Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.3501 mL | 6.7504 mL | 13.5007 mL | 27.0015 mL | 33.7519 mL |
5 mM | 0.27 mL | 1.3501 mL | 2.7001 mL | 5.4003 mL | 6.7504 mL |
10 mM | 0.135 mL | 0.675 mL | 1.3501 mL | 2.7001 mL | 3.3752 mL |
50 mM | 0.027 mL | 0.135 mL | 0.27 mL | 0.54 mL | 0.675 mL |
100 mM | 0.0135 mL | 0.0675 mL | 0.135 mL | 0.27 mL | 0.3375 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Oleamide
Catalog No.:BCC6827
CAS No.:301-02-0
- Methyl Linolenate
Catalog No.:BCN8318
CAS No.:301-00-8
- 4-CMTB
Catalog No.:BCC6250
CAS No.:300851-67-6
- GSA 10
Catalog No.:BCC6329
CAS No.:300833-95-8
- Ciluprevir (BILN-2061)
Catalog No.:BCC1482
CAS No.:300832-84-2
- RS 504393
Catalog No.:BCC1910
CAS No.:300816-15-3
- TG003
Catalog No.:BCC4416
CAS No.:300801-52-9
- BMS 309403
Catalog No.:BCC8046
CAS No.:300657-03-8
- HMBA Linker
Catalog No.:BCC2831
CAS No.:3006-96-0
- SKF 77434 hydrobromide
Catalog No.:BCC7144
CAS No.:300561-58-4
- Dehydrocorydalin
Catalog No.:BCN2474
CAS No.:30045-16-0
- Boc-Asn-ol
Catalog No.:BCC2587
CAS No.:30044-67-8
- Malvidin-3-O-galactoside chloride
Catalog No.:BCN3030
CAS No.:30113-37-2
- Tianeptine sodium
Catalog No.:BCC2506
CAS No.:30123-17-2
- TCS 359
Catalog No.:BCC1183
CAS No.:301305-73-7
- CH 223191
Catalog No.:BCC3896
CAS No.:301326-22-7
- P7C3
Catalog No.:BCC6524
CAS No.:301353-96-8
- H-Val-NH2.HCl
Catalog No.:BCC3144
CAS No.:3014-80-0
- Seneganolide
Catalog No.:BCN5209
CAS No.:301530-12-1
- Compstatin control peptide
Catalog No.:BCC6067
CAS No.:301544-78-5
- Jasminin
Catalog No.:BCN7468
CAS No.:30164-93-3
- SB 431542
Catalog No.:BCC3658
CAS No.:301836-41-9
- D4476
Catalog No.:BCC1508
CAS No.:301836-43-1
- Boc-Lys(Boc)-OSu
Catalog No.:BCC3415
CAS No.:30189-36-7
Robinin modulates doxorubicin-induced cardiac apoptosis by TGF-beta1 signaling pathway in Sprague Dawley rats.[Pubmed:25443416]
Biomed Pharmacother. 2014 Oct;68(8):989-98.
The study focussed on the cardioprotective effect of Robinin on doxorubicin-induced cardio-toxicity in Sprague Dawley rats. After the experimental period, animals were sacrificed and the various parameters such as cardiac markers, toxicity parameters, antioxidant status, ROS generation, lipid peroxidation status and inflammatory parameters were assessed. Gene expression study by RT-PCR analysis and proteins expression study by western blotting were done. Doxorubicin causes significant increase in the levels of cardiac marker enzymes, namely lactate dehydrogenase (LDH), creatine phospokinase (CPK), toxicity parameters like serum glutamate oxaloacetate transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT). Antioxidant enzyme levels were decreased; lipid peroxidation products in heart tissue and inflammatory markers, namely cyclooxygenase (COX2) and lipooxygenase (LOX15) were significantly increased. Gene expression study by RT-PCR analysis of transforming growth factor-beta1 (TGF-beta1), Smad2, murine double minute (Mdm2), Smad3, cyclin-dependent kinase inhibitor 2A (CDKN2A), Smad4 and Smad7 were significantly altered. The western blotting study of p53, Bcl-2 and Bax also showed altered expression. The supplementation of the Robinin along with DOX caused normalised level of all the above parameters and cardio-toxicity. This study revealed the cardioprotective nature of Robinin on doxorubicin-induced cardiac toxicity by modulating TGF-beta1 signaling pathway in Sprague Dawley rats.
Robinin modulates TLR/NF-kappaB signaling pathway in oxidized LDL induced human peripheral blood mononuclear cells.[Pubmed:24295649]
Int Immunopharmacol. 2014 Jan;18(1):191-7.
This study was designed to investigate whether Robinin administration modulates toll-like receptor (TLR) and nuclear factor-kappa B (NF-kappaB) signaling pathway in oxidized LDL induced human peripheral blood mononuclear cells (hPBMCs). The hPBMCs were isolated from healthy human volunteers and the cells were cultured in collagen coated plates at 37 degrees C with 5% CO2 and RPMI as culture medium and were grouped as follows: Group I - control, group II - OxLDL treated and group III - OxLDL+Robinin (6mug/ml). We measured mRNA expression of TLR2 and TLR4 by reverse-transcriptase polymerase chain reaction (RT-PCR) and NF-kappaB transcription factor assay (ELISA), and western blotting studies were done for knowing expression of monocyte chemotactic protein-1 (MCP 1), tumor necrosis factor-alpha (TNF-alpha) interleukin-6 (IL-6) and vascular cell adhesion molecule 1 (VCAM-1). The result indicates that OxLDL that induces hPBMCs showed an upregulated expression of TLR2, TLR4, NF-kappaB, pro-inflammatory cytokines and VCAM-1. Robinin inhibited the ox-LDL induced TLR2 and TLR4 expression at mRNA level and inhibited the translocation of NF-kappaB p65 by modulating the TLR-NF-kappaB signaling pathway thereby inhibiting cytokine production and down regulated inflammatory enzymes like cyclooxygenase (COX), lipoxygenase (LOX), nitric oxide synthase (NOS) and prostaglandin E2 (PGE2), thus having protective effect against the ox-LDL induced inflammation stress in hPBMCs by inhibiting TLR4-NF-kappaB signaling pathway.
Simultaneous determination of the flavonoids robinin and kaempferol in human breast cancer cells by liquid chromatography-tandem mass spectrometry.[Pubmed:21232900]
J Pharm Biomed Anal. 2011 Apr 28;55(1):109-13.
An accurate, precise and sensitive method was developed and validated for the simultaneous quantification of the flavonoid glycoside Robinin, and its algycone kaempferol in human breast cancer MCF-7 cells. The application of liquid chromatography-tandem mass spectrometry (LC/MS/MS) with a TurboIonspray interface in negative mode under multiple reactions monitoring was investigated. Chromatographic separation was achieved on a C(18) column using a mobile phase consisting of (A) water with 0.025% formic acid and 1mM ammonium formate and (B) acetonitrile with 0.025% formic acid. Rutin was used as the internal standard for Robinin and fisetin as the internal standard for kaempferol. The assay had a limit of detection of 0.1ng/ml for both compounds when present in cell lysate. The calibration curves were linear from 1 to 250ng/ml (r>0.999) for each compound. The intra- and inter-day coefficients of variation were less than 10% and intra- and inter-day accuracies were within 11%. This assay was successfully applied in a Robinin cellular uptake study to determine the intracellular concentrations of Robinin in MCF-7 cells.